Cargando…
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
PPARγ and PPARδ agonists represent unique classes of drugs that act through their ability to modulate gene transcription associated with intermediary metabolism, differentiation, tumor suppression, and in some instances proliferation and cell adhesion. PPARγ agonists are used by millions of people e...
Autores principales: | Glazer, Robert I., Yuan, Hongyan, Xie, Zhihui, Yin, Yuzhi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430014/ https://www.ncbi.nlm.nih.gov/pubmed/18566686 http://dx.doi.org/10.1155/2008/247379 |
Ejemplares similares
-
PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
por: Glazer, Robert I.
Publicado: (2016) -
Ligand Modulated Antagonism of PPARγ by Genomic and Non-Genomic Actions of PPARδ
por: Gustafsson, Mattias C. U., et al.
Publicado: (2009) -
PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis
por: Pollock, Claire B., et al.
Publicado: (2011) -
Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015) -
NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
por: Mackenzie, Gerardo G., et al.
Publicado: (2008)